YANn Pierson, PhD
Yann Pierson earned a PhD in chemical biology from EPFL in 2018. He studied biochemistry at EPFL and at the National University of Singapore. A passionate and self-taught maker, he designed and prototyped the technology behind Limula Biotech revolutionary platform. His role is to constantly improve the product to fit users’ needs.
Luc HEnry, DPhil (oxon)
Luc Henry earned a DPhil (PhD) from the University of Oxford in 2012. He is a skilled scientist, with a broad technical and theoretical background in chemistry, biotechnology and cell biology. Luc is an advisor to Martin Vetterli, the current President of EPFL. At Limula, his role is to develop real-world applications for the technology through meaningful partnerships.
Matthias Lütolf is Full Professor at EPFL’s Institute of Bioengineering, with a cross appointment in the Institute of Chemical Sciences and Engineering. His research is at the interface of stem cell biology and bioengineering to gain fundamental insight into how complex 3D microenvironments control the behavior of stem cells. His team develops novel technologies for maintaining stem cells in vitro and for controlling their differentiation and self-organization into 3D functional organoids.
Marta Gehring is a consultant at sbg Healthcare and ORSCO Lifesciences, focusing on business development of medical innovation. She has extensive experience in marketing, sales and general management, having held senior positions with prominent Biotech and Medtech multinationals in the EMA arena. She is a startup coach with Innosuisse, the Swiss innovation agency.
Olivier Waridel is a serial entrepreneur and a consultant for start-up/mid-size medical device companies. He was the CEO of Biosafe Group SA, now part of GE Healthcare Life Sciences and the industry standard in the field of adult stem cell therapy, providing stem cell banks, hospitals and research institutes with innovative cell processing solutions.